Related Image: Urgent Care Provider NextCare Announces new Board of Directors |
(Date:11/21/2008)...Newswire-USNewswire/ -- New research at West Virg... spitless tobacco product aimed at young adults is...RJ Reynolds, Camel Snus - touted as a socially acc...singly high levels of nicotine. , , "Camel ...products," said Bruce Adkins of the state Division...
(Date:11/21/2008)...swire-USNewswire/ -- U.S. News & World Report ...NCQA) ranked BlueChoice(R) HealthPlan of South Car...ans(TM), published in U.S. News & World Report...l ranking ranks the nation,s best health plans bas...QA accreditation scores. NCQA and U.S. News & ...
(Date:11/21/2008)...swire-FirstCall/ -- Barr Pharmaceuticals, Inc. (NY...overwhelmingly approved the proposals submitted to...Pharmaceuticals Industries Ltd. (Nasdaq: TEVA )....elming support of the transaction by the Barr shar...nd CEO. "We are pleased with the progress that we ...
(Date:11/21/2008)...y diseaseits cause remains a mysteryswept into Ath...citizens, soldiers and refugees of the war then ra...with corpses, social order broke down. Over the ne...ens lost a third of its population. It lost the wa...f the end of the Golden Age of Greece. , The Pl...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4(Date:11/20/2008)... New Jersey American Water has lifted the precaut...he following municipalities in Middlesex, Somerset..., , , Dunellen , Edison , ...lainfield , , , , Somerset County ,...er , Green Brook , Hillsborough , ...
(Date:11/20/2008)...ewswire-FirstCall/ -- Arpida (SWX:,ARPN) announce...mittee of the,U.S. Food and Drug Administration (...travenous iclaprim, an antibiotic currently in dev...icated skin and skin structure infections,(cSSSIs... Staphylococcus,aureus (MRSA). , Arpida re...
(Date:11/20/2008)...tCall/ -- Duska Therapeutics,Inc., (OTC Bulletin...ed its,pivotal Phase 3 ATPace clinical trial prot...nt (SPA) procedure with the U.S. Food and Drug Adm...n agreement with the FDA, Duska intends to initiat...ntrolled and randomized Phase 3,clinical trial wi...
(Date:11/20/2008)...PAREXEL International Corporation (Nasdaq: PRXL ...vider, today announced that it has opened an offic...nd clinical research capabilities. With the additi...hroughout five important biopharmaceutical centers...razil, Chile, and Mexico. This expansion further s...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Chemo for Mesothelioma Offers Limited Survival Benefits 19551 1Chemo for Mesothelioma Offers Limited Survival Benefits 19551 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 1Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 2Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 3Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 4Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 5Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 6Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 7Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 8Select Medical Corporation Announces Results for First Quarter Ended March 31 2008 19549 9AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 1AARP Statement on Governors Bill for Prescription Drug Marketing Reform and Transparency 19547 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 1Senetek PLC Reports First Quarter 2008 Financial Results 5462 2Senetek PLC Reports First Quarter 2008 Financial Results 5462 3...D Are at High,Risk , ,WASHINGTON, March 9, 2007 ...family history of end-stage renal disease (ESRD), ...sk of developing,kidney disease themselves, report...iety of Nephrology. , "A family history of kidney ... are also at substantially higher risk of,ESRD," c...
...07 /PRNewswire-FirstCall/ - Chemokine,Therapeutics... , a,biotechnology company developing chemokine-ba...d vascular disease today announced,positive prelim...se-escalation portion of its Phase Ib/II clinical ...g candidate. No dose,limiting toxicities were obse...
Other Medicine Technology:Nearly 1 in 10 Americans Has A Relative With Kidney Failure 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...he Portex® Thermovent® T helps provide pro...patient. It is small and extremely lightweight mak...adults. With a high rate of heat and moisture reco...tion retention., ,All HMEs and filters have ISO s...
...even digital models cover the range from 2ul to 50...ume lock design prevents inadvertent volume change...ip. Whole pipette is autoclavable at 121C(250F). ...ropylene. Suitable for one-handed operation. Aut...
...he AlphaPette Pipettor is the #1 Pipettor for sub-...comfort, and reliability. Continuously adjustable....dout sub-micrometer. Easy interchangeable ejector ...le rapid pipet tip ejector with three different le...
Medicine Products: